Trulieve Cannabis (TCNNF) Income from Non-Controlling Interests (2022 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Income from Non-Controlling Interests of -$123000.0 in Q1 2026, down 102.38% quarter-over-quarter from $5.2 million in Q4 2025, and up 86.16% on a YoY basis from -$66070.7 in Q1 2025.
Trulieve Cannabis (TCNNF) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
Trulieve Cannabis' Income from Non-Controlling Interests history runs 5 years deep, the most recent figure standing at -$123000.0 for Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests rose 86.16% year-over-year to -$123000.0; the TTM figure through Mar 2026 stood at $766000.0 (up 116.68% YoY), while the FY2024 annual figure was -$5.5 million, down 358.68% from the prior year.
- Income from Non-Controlling Interests was -$123000.0 for Q1 2026 at Trulieve Cannabis, down from $5.2 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $5.2 million in Q4 2025 to a low of -$2.4 million in Q2 2023.
- Historically, Income from Non-Controlling Interests has averaged -$556000.0 across 5 years, with a median of -$889000.0 in 2025.
- Biggest YoY gain for Income from Non-Controlling Interests was 390.88% in 2025; the steepest drop was 720.77% in 2025.
- A 5-year view of Income from Non-Controlling Interests shows it stood at -$1.4 million in 2022, then surged by 280.33% to $2.6 million in 2023, then sank by 168.48% to -$1.8 million in 2024, then soared by 390.88% to $5.2 million in 2025, then sank by 102.38% to -$123000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$123000.0 (Q1 2026), $5.2 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | -123,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -123,000.00 |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | -2.33 Mn |
| Mar 31, 2025 | -889,000.00 |
| Dec 31, 2024 | -1.78 Mn |
| Sep 30, 2024 | -1.64 Mn |
| Jun 30, 2024 | -284,000.00 |
| Mar 31, 2024 | -1.77 Mn |
| Dec 31, 2023 | 2.60 Mn |
| Jun 30, 2023 | -2.35 Mn |
| Mar 31, 2023 | -523,000.00 |
| Dec 31, 2022 | -1.44 Mn |
| Sep 30, 2022 | -518,000.00 |
| Mar 31, 2022 | -507,000.00 |